Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Noelle van der Voort van Zyp"'
Autor:
Edith Dieleman, Lisa van der Woude, Rob van Os, Liselotte van Bockel, Ida Coremans, Corine van Es, Katrien De Jaeger, Hans Peter Knol, Willemijn Kolff, Frederike Koppe, Jacqueline Pomp, Bart Reymen, Dominic Schinagl, Femke Spoelstra, Caroline Tissing-Tan, Noelle van der Voort van Zyp, Antoinet van der Wel, Robin Wijsman, Michel Dielwart, Erwin Wiegman, Ronald Damhuis, Jose Belderbos
Publikováno v:
Clinical Lung Cancer, 24, 2, pp. 130-136
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
In this national lung cancer audit of inoperable NSCLC patients, acute toxicity and 3-month mortality of curative chemoradiation was analyzed. Another important question was whether concurrent chemoradiation for elderly stage III NSCLC patients is sa
Autor:
Noëlle van der Voort van Zyp, Masoma Hashimzadah, Erik Kouwenhoven, Carmen Liskamp, Christa Gadellaa-van Hooijdonk, Ellen Pouw, Jose Belderbos, Klaartje Maas, Paul van de Vaart, Mirjam Mast
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 36, Iss , Pp 70-76 (2022)
Introduction: Concurrent chemoradiation followed by immunotherapy is the standard of care for patients with stage III non-small cell lung cancer (NSCLC). Prior to the introduction of adjuvant immunotherapy, we treated patients with stage III NSCLC wi
Externí odkaz:
https://doaj.org/article/67b980b5c1374de88616d34468bdd3fd